Jakob L Fischer,Anthony M Tolisano,Stacy L Strausborger et al.
Jakob L Fischer et al.
Evaluation of Nocturnal Enuresis After Adenotonsillectomy in Children With Obstructive Sleep Apnea: A Secondary Analysis of a Randomized Clinical Trial [0.03%]
儿童阻塞性睡眠呼吸暂停的夜间遗尿评估：一项随机临床试验的二次分析
Aaron Snow,Turaj Vazifedan,Cristina M Baldassari
Aaron Snow
Importance: Children with obstructive sleep apnea (OSA) are at increased risk for nocturnal enuresis (NE). However, randomized clinical trials assessing NE outcomes in children randomized to adenotonsillectomy (AT) vs wat...
Randomized Controlled Trial
JAMA otolaryngology-- head & neck surgery. 2021 Oct 1;147(10):887-892. DOI:10.1001/jamaoto.2021.2303 2021
Neck Mass in an Adolescent [0.03%]
青少年颈部长肿块
Saikrishna C Gourishetti,Jamie Hittman,Kevin D Pereira
Saikrishna C Gourishetti
Zdenek Knížek,Roman Michálek,Jan Vodicka et al.
Zdenek Knížek et al.
Patients' Views of Shared Decision-making and Decisional Conflict in Otolaryngologic Surgery During the COVID-19 Pandemic [0.03%]
新冠疫情期间头颈外科手术患者决策冲突与共同决策观点调查研究
Nneoma S Wamkpah,Sophie P Gerndt,Dorina Kallogjeri et al.
Nneoma S Wamkpah et al.
Importance: A patient's decision to undergo surgery may be fraught with uncertainty and decisional conflict. The unpredictable nature of the COVID-19 pandemic warrants further study into factors associated with patient de...
Vinay K Rathi,Roy Xiao,Rosh K V Sethi
Vinay K Rathi
Intraoperative Parathyroid Hormone in Minimally Invasive Parathyroidectomy [0.03%]
微创甲状旁腺切除术中的术中降钙素监测
Tam-Lin Chow
Tam-Lin Chow
Intraoperative Parathyroid Hormone in Minimally Invasive Parathyroidectomy-Reply [0.03%]
微创甲状旁腺切除术中的术中甲状旁腺激素检测——关于论著的回复
Alanna J Quinn,Éanna J Ryan,Aoife J Lowery
Alanna J Quinn
Catherine F Poh,J Scott Durham
Catherine F Poh
Neoadjuvant PD-1/PD-L1 Inhibitors for Resectable Head and Neck Cancer: A Systematic Review and Meta-analysis [0.03%]
可切除性头颈癌患者使用PD-1/PD-L1抑制剂进行新辅助治疗：系统性回顾和荟萃分析
Razan Masarwy,Liyona Kampel,Gilad Horowitz et al.
Razan Masarwy et al.
Importance: The emerging approach of neoadjuvant immunotherapy for solid cancers has set the ground for the integration of programmed cell death 1 (PD-1)/PD-1 ligand 1 (PD-L1) inhibitors into the neoadjuvant setting of he...